A Study to Examine the Potential Effect of Lansoprazole on the Pharmacokinetics of Bosutinib When Administered Concomitantly to Healthy Subjects.

Trial Profile

A Study to Examine the Potential Effect of Lansoprazole on the Pharmacokinetics of Bosutinib When Administered Concomitantly to Healthy Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 28 Apr 2011

At a glance

  • Drugs Bosutinib; Lansoprazole
  • Indications Acute lymphoblastic leukaemia; Breast cancer; Chronic myeloid leukaemia; Duodenal ulcer; Dyspepsia; Gastric ulcer; Gastro-oesophageal reflux; Heartburn; Helicobacter infections; NSAID-induced ulcer; Peptic ulcer; Solid tumours; Zollinger-Ellison syndrome
  • Focus Pharmacokinetics
  • Sponsors Wyeth
  • Most Recent Events

    • 28 Apr 2011 Last checked against ClinicalTrials.gov record.
    • 18 Apr 2011 Planned End Date changed from 1 Sep 2009 to 2 Sep 2009, according to ClinicalTrials.gov record.
    • 03 Sep 2010 Additional location [USA] identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top